hydroxyurea has been researched along with Lung Diseases in 14 studies
Lung Diseases: Pathological processes involving any part of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We exposed 21-d-old rats to room air or continuous 95% oxygen for 7 d and then allocated them into 6 groups to evaluate whether treatment with zileuton and zafirlukast, 2 agents which decrease the effects of leukotrienes, lessened the pulmonary effects of short-term hyperoxia." | 3.74 | Effects of leukotriene inhibition on pulmonary morphology in rat pup lungs exposed to hyperoxia. ( Funk, AJ; Kosanke, SD; Li, CS; Lokey, SJ; Mandrell, TD; Potters, CF, 2007) |
| " Our results, while no longer the product of a randomized study because of the ethical concerns of withholding an efficacious treatment, suggest that long-term use of hydroxyurea is safe and might decrease mortality." | 2.75 | The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up. ( Armstrong, FD; Ataga, K; Ballas, SK; Castro, O; DeCastro, L; Kutlar, A; McCarthy, WF; Smith, W; Steinberg, MH; Swerdlow, P; Waclawiw, MA, 2010) |
| "Sickle cell disease is a recessively inherited condition in which synthesis of haemoglobin is abnormal." | 2.41 | Acute complications of sickle cell disease in children. ( , 2001) |
| "Sickle cell disease is the most common inherited disease in the U." | 1.35 | The clinical care of adult patients with sickle cell disease. ( Howard, J; Olujohungbe, A, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (21.43) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buckner, TW | 1 |
| Ataga, KI | 1 |
| Noronha, SA | 1 |
| Sadreameli, SC | 1 |
| Strouse, JJ | 1 |
| Olujohungbe, A | 1 |
| Howard, J | 1 |
| Steinberg, MH | 1 |
| McCarthy, WF | 1 |
| Castro, O | 1 |
| Ballas, SK | 1 |
| Armstrong, FD | 1 |
| Smith, W | 1 |
| Ataga, K | 1 |
| Swerdlow, P | 2 |
| Kutlar, A | 1 |
| DeCastro, L | 1 |
| Waclawiw, MA | 1 |
| Tripathi, A | 1 |
| Jerrell, JM | 1 |
| Stallworth, JR | 1 |
| McCavit, TL | 1 |
| Girgis, RE | 1 |
| Qureshi, MA | 1 |
| Abrams, J | 1 |
| Funk, AJ | 1 |
| Mandrell, TD | 1 |
| Lokey, SJ | 1 |
| Kosanke, SD | 1 |
| Li, CS | 1 |
| Potters, CF | 1 |
| Fawibe, AE | 1 |
| Hillyer, MH | 1 |
| Mair, TS | 1 |
| Goldblum, SE | 1 |
| Wu, KM | 1 |
| Jay, M | 1 |
| von Eyben, FE | 1 |
| Siddiqui, MZ | 1 |
| Spanos, G | 1 |
| Cochran, KW | 1 |
| Maassab, HF | 1 |
5 reviews available for hydroxyurea and Lung Diseases
| Article | Year |
|---|---|
Does hydroxyurea prevent pulmonary complications of sickle cell disease?
Topics: Anemia, Sickle Cell; Humans; Hydroxyurea; Lung Diseases; Practice Guidelines as Topic; Publications | 2014 |
Management of Sickle Cell Disease in Children.
Topics: Anemia, Sickle Cell; Antisickling Agents; Child; Gastrointestinal Diseases; Heart Diseases; Humans; | 2016 |
Sickle cell disease.
Topics: Acute Pain; Anemia, Sickle Cell; Antisickling Agents; Bone Marrow Transplantation; Erythrocyte Trans | 2012 |
Managing acute chest syndrome of sickle cell disease in an African setting.
Topics: Acute Disease; Anemia, Sickle Cell; Antisickling Agents; Diagnosis, Differential; Humans; Hydroxyure | 2008 |
Acute complications of sickle cell disease in children.
Topics: Abdominal Pain; Acute Disease; Adolescent; Analgesics; Anemia, Aplastic; Anemia, Sickle Cell; Animal | 2001 |
1 trial available for hydroxyurea and Lung Diseases
| Article | Year |
|---|---|
The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up.
Topics: Adolescent; Adult; Anemia, Sickle Cell; DNA Damage; Drug Utilization; Early Termination of Clinical | 2010 |
8 other studies available for hydroxyurea and Lung Diseases
| Article | Year |
|---|---|
The clinical care of adult patients with sickle cell disease.
Topics: Adult; Anemia, Sickle Cell; Antisickling Agents; Female; Genetic Testing; Heart Diseases; Humans; Hy | 2008 |
Clinical complications in severe pediatric sickle cell disease and the impact of hydroxyurea.
Topics: Adolescent; Anemia, Sickle Cell; Antisickling Agents; Cardiovascular Diseases; Child; Child, Prescho | 2011 |
Decreased exhaled nitric oxide in sickle cell disease: relationship with chronic lung involvement.
Topics: Adult; Anemia, Sickle Cell; Breath Tests; Chronic Disease; Dyspnea; Female; Hemoglobins; Humans; Hyd | 2003 |
Effects of leukotriene inhibition on pulmonary morphology in rat pup lungs exposed to hyperoxia.
Topics: Animals; Animals, Newborn; Female; Hydroxyurea; Hyperoxia; Indoles; Leukotriene Antagonists; Lung; L | 2007 |
Multisystemic eosinophilic epitheliotropic disease in a horse: attempted treatment with hydroxyurea and dexamethasone.
Topics: Animals; Dexamethasone; Eosinophilia; Epithelium; Female; Gastrointestinal Diseases; Horse Diseases; | 1992 |
Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits.
Topics: Animals; Cyclophosphamide; Granulocytes; Hydroxyurea; Lung; Lung Diseases; Peroxidase; Rabbits; Resp | 1985 |
High-voltage irradiation and hydroxyurea for pulmonary leukostasis in acute myelomonocytic leukemia.
Topics: Adult; Combined Modality Therapy; Humans; Hydroxyurea; Leukemia, Myeloid, Acute; Lung Diseases; Male | 1987 |
Inhibition of a cold variant of influenza virus by selected chemicals.
Topics: Amantadine; Ammonium Chloride; Animals; Antiviral Agents; Culture Techniques; Cysteine; Glycosides; | 1970 |